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Background: Despite the efficacy of molecular targeted therapy, surgical resection remains the only curative
primary treatment for gastrointestinal stromal tumors (GISTs). However, in cases when the tumor originates from
the thoracic esophagus, conventional transthoracic approach is highly invasive.
Methods: All procedures were performed with patients in a prone position through a double-lumen endotracheal
tube for single-lung ventilation. First, to clarify the resection layer between the tumor and mucosal layer of the
esophagus, a sodium hyaluronate solution colored with indigo carmine was injected into the submucosa via the
esophagoscopic approach. Second, we thoracoscopically divided the longitudinal muscle of the esophagus and
enucleated the tumor through three ports by dissecting along the artificially colored submucosa, thereby minimizing
accidentally opening of the esophageal mucosa. Third, we sutured the divided longitudinal muscle layer and removed
the tumor from the thoracic cavity.
Results: Four tumors, including one GIST, were successfully resected via this hybrid approach. The mean
surgical time was 137.7 min (range, 60–231 min), and the mean blood loss was 21.2 ml (range, 3–65 ml).
No perioperative complications occurred, including with accidental opening of the esophageal mucosa.
Conclusions: Our minimally invasive hybrid surgery combined with esophagoscopic and thoracoscopic approaches
demonstrated successful resection. This surgery could have advantages both for curing esophageal submucosal tumor
and for minimizing surgical invasiveness.
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Even with the recent advances in diagnostic modalities,
a correct diagnosis of submucosal tumors (SMTs) originat-
ing from the esophagus is still challenging [1-4]. In cases
when the tumor is larger than 3 cm in size, surgical resec-
tion is recommended for definitive diagnosis and treatment
due to a higher risk of malignancy [1]. For the surgical re-
section of gastrointestinal stromal tumors (GISTs) origin-
ating from the thoracic esophagus, thoracotomy with* Correspondence: hdaikou@east.ncc.go.jp
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unless otherwise stated.esophagectomy is still the preferred approach, particu-
larly in cases when the tumor is relatively large in
size. However, this procedure is usually accompanying
large operation scar with reconstruction of the gastric
tube. This results in postoperative pain and a relatively
higher incidence of accidental opening of the esophageal
mucosa [5,6].
With patients in a prone position, thoracoscopic esoph-
agectomy has been reported to be safe and effective,
resulting in sufficient surgical outcomes for cancer of the
thoracic esophagus [7]. The thoracoscopic approach with
patients in a prone position provides an excellent surgical
field that makes dissection easier because the physicalhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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the surgical procedures and outcomes of our minimally
invasive hybrid approach combined with esophagoscopy
and thoracoscopy for enucleating SMTs originating from
the thoracic esophagus.
Methods
Human rights statement and informed consent
All procedures followed were in accordance with the
ethical standards of the responsible committee on hu-
man experimentation and with the Helsinki Declaration
of 1964 and later versions. Informed consent or substi-
tute for it was obtained from all patients for being in-
cluded in the study. Patient data were retrospectively
evaluated after receiving approval from our institution’s
investigational review board with the approval code of
012-0045.
Surgical position
All procedures were performed with patients under gen-
eral anesthesia through a double-lumen endotracheal
tube for single-lung ventilation. After intubation, each
patient was placed in a prone position on a surgical bean
bag, and the patient’s right arm was raised cranially. The
surgeon and camera surgeon stood on the patient’s right
side. The esophagoscopist stood at the patient’s head
(right side), while the endoscopy cart with the monitor
was positioned on the other side. Written informed con-
sents were obtained from the patients for the publication
of this report and any accompanying images.
Esophagoscopy
Esophagoscopy and thoracoscopy were initiated simultan-
eously. A single-channel videoscope (Olympus GIF-Q260,
Tokyo, Japan) was used for esophagoscopy. A sodium
hyaluronate solution (MucoUp™; Seikagaku Corporation,
Tokyo, Japan) colored blue by indigo carmine was injected
into the submucosal layer to highlight the incision layer
and was used to define the space between the tumor and
submucosal layer (Figure 1).Figure 1 Schematic representation of esophagoscopic approach and
hyaluronate solution colored blue by indigo carmine was injected into the
between the tumor and submucosal layer.Thoracoscopy
Thoracoscopy was performed by the surgeon and camera
surgeon through three observation ports. Port I was a
12-mm blunt port at the seventh intercostal space (ICS)
on the middle axillary line for the left-handed procedure.
Port II was a 5-mm port at the fifth ICS on the middle
axillary line for the right-handed procedure. Port III was a
5-mm port at the ninth ICS on the posterior axillary line
where a 5-mm-diameter flexible endoscope was inserted
(Figure 2). Carbon dioxide was usually insufflated at a
pressure of 8–10 mmHg to expand the mediastinum.
Thoracoscopy through a three-port approach was suffi-
cient to obtain optical dissection of the submucosal layer,
which was artificially colored blue with MucoUp™ (Figure 1).
Thoracoscopy consists of four steps. First, the medias-
tinal pleura was incised longitudinally along with the ven-
tral border of the azygos vein; this procedure enabled
adequate exposure of the tumor. The esophagus was then
mobilized from the surrounding tissue to allow a distance
of 2 cm from the esophageal tumor to acquire optimal
space for the subsequent procedure. Second, the outer
longitudinal muscle layer over the tumor was incised and
dissected down to the tumor level to preserve the inner
circular muscle layer. Third, the internal circular muscle
layer was divided, and the thickened submucosal layer
marked by indigo carmine was identified. Careful enucle-
ation of the circular muscle layer was performed by elec-
trocautery in this blue marked plane, without accidental
opening of the mucosa. Fourth, the opened outer longitu-
dinal muscle was repaired by a running suture using ab-
sorbable thread (Figure 3). The resected tumor was put
into a surgical bag (Endo Catch™) and removed from the
thoracic cavity through an expanded seventh ICS port
(when a tumor is too large to be removed through an
intercostal space, it is removed through an additional hori-
zontal incision of the upper abdomen through the dia-
phragm without laparotomy). After carefully investigating
for accidental opening of the esophageal mucosa, a single
20-F chest tube was inserted through the ninth ICS port
for proper drainage.injection of blue-colored sodium hyaluronate solution. Sodium
submucosal layer to define the incision layer and create a space
Figure 2 Schematic representation of the thoracoscopic three-port approach. Port I is a 12-mm blunt port at the seventh intercostal space
(ICS) on the middle axillary line for the left-handed procedure. Port II is a 5-mm port at the fifth ICS on the middle axillary line for the right-handed
procedure. Port III is a 5-mm port at the ninth ICS on the posterior axillary line for the insertion of a 5-mm-diameter flexible endoscope.
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Surgical outcomes
All four patients underwent complete thoracoscopic enu-
cleation through three ports without access thoracotomy
(Figure 4). The tumors of patients 1 and 2 were resectedFigure 3 Representative images of endoscopic and thoracoscopic pro
injection of the blue-colored sodium hyaluronate solution. (b) Endoscopic
solution. (c) Surgical finding after the dissection of the longitudinal mu
the longitudinal muscle layer of the esophagus.from the port sites. The huge tumor of patient 3 was
resected without laparotomy through an additional 4-cm
horizontal incision of the upper abdomen just below the
costal arch. A summary of clinical characteristics and
surgical outcomes of these four patients are shown incedures. (a) Endoscopic finding of the submucosal tumor before
finding after the injection of the blue-colored sodium hyaluronate
scle layer of the esophagus. (d) Surgical finding after the suture of
Figure 4 Findings of contrast-enhanced computed tomography,
barium-swallow esophagogram and endoscopy in four cases.
(1) Gastrointestinal stromal tumor located on the left side of the
middle third of the thoracic esophagus. (2) Tumor located on the
lower third of the esophagus was histopathologically diagnosed
as leiomyoma. (3) Large tumor located on the lower third of the
esophagus was histopathologically diagnosed as leiomyoma. (4) Tumor
located on the lower third of the esophagus was histopathologically
diagnosed as leiomyoma.
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60–231 min), and the mean blood loss was 21.2 ml (range,
3–65 ml). No intra- or perioperative complications oc-
curred, nor did any surgical deaths.
Pathological diagnosis
One of four tumors was positive for c-kit and CD34
expression, with a mitotic index of 3/50 high-power
fields; this tumor was ultimately diagnosed as GIST of
the esophagus, with a low risk of aggressive behavior. Three
of four tumors were negative for both c-kit and CD34
expression following immunohistochemical investigation.
In all cases, resection margins were histopathologically
proven as being free from tumors (Table 2).Table 1 Clinical characteristics and surgical outcomes of four






1 Male 38 Mt 3.5 127
2 Female 43 Lt 5.0 133
3 Female 69 Lt/Mt 9.0 231
4 Female 38 Lt 3.0 60
Mt middle third of esophagus, Lt lower third of esophagus.Discussion
Because of similar clinical, endoscopic, and radiographic
appearances, a correct diagnosis of SMTs originating from
the esophagus is often challenging, even with clinically
apparent symptoms. Although SMTs of esophageal origin
share similar clinical and radiographic characteristics, leio-
myoma, leiomyosarcoma, and GISTs are distinct pathologic
entities. Therefore, a correct diagnosis of SMTs originating
from the esophagus is pivotal for the further manage-
ment of patients with these entities. To clearly diagnose
SMTs originating from the esophagus, several diagnostic
methods are available. Because GISTs are fluorodeoxyglu-
cose (FDG)-avid, FDG positron emission tomography
(PET) scanning may be used to differentiate GISTs from
leiomyoma [8]. Furthermore, GISTs can be reliably identi-
fied preoperatively by endoscopic ultrasound (EUS)-guided
FNA. However, even EUS-guided FNA lacks the capacity
to differentiate between benign and malignant tumors, and
normal findings do not exclude the possibility of malig-
nancy by small specimens [9,10]. Therefore, most common
esophageal SMTs are not definitely diagnosed until after
resection and subsequent pathological examinations.
SMTs larger than 3 cm in diameter suggest the need for
treatment due to their high risk of malignancy [1]. Thus,
we suggest that if SMT meets the following criteria, surgi-
cal resection should be recommended for diagnosis and
treatment: (1) the tumor causes symptoms, (2) tumor size
is larger than 3 cm, (3) radiologic examination reveals a
malignant finding or suspected malignancy, and (4) cyto-
logical or pathological examination reveals a malignant
finding or suspected malignancy.
Recent advances in thoracoscopic surgery enable us to
minimize the procedure to remove SMTs originating from
the esophagus. However, enucleation of thoracic esopha-
geal SMTs through a thoracoscopic approach occasionally
results in accidental opening of the esophageal mucosa
[5,6]. Minimally invasive esophageal surgery such as
thoracoscopic esophagectomy with patients in a prone
position has demonstrated sufficient short-term outcomes
and oncological results [7]. This surgical approach has
gained widespread acceptance not only for thoracic esoph-
agectomy but also for enucleation of SMT originating
from the thoracic esophagus. Yamada et al. reported thor-










5 3 10 None
12 3 9 None
65 3 6 None
3 3 4 None
Table 2 Immunohistopathological staining and
pathological diagnosis of the tumor
Patient c-kit CD34 Desmin S-100 SMA Diagnosis
1 + + + − + GIST
2 − − + − + Leiomyoma
3 − − + − + Leiomyoma
4 − − + − + Leiomyoma
SMA α-smooth muscle actin.
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et al. also demonstrated the safety and efficacy of video-
assisted thoracic surgery for enucleation of esophageal
submucosal tumors [12]. Furthermore, we combined thor-
acoscopy with esophagoscopy for maximized complete re-
section of the tumor, while minimizing exposure of the
esophageal lumen by making blue-colored resection layer
in the submucosa using endoscopy. Moreover, using our
hybrid surgery, thoracoscopic enucleation can be easily
performed through only three access ports, which has the
advantage of reducing postoperative pain.
Conclusions
This approach is less invasive and safe and facilitates tumor
enucleation, resulting in early postoperative recovery. With
all these benefits, our hybrid surgical technique has the
potential to be highly effective against SMTs originating
from the thoracic esophagus, including GISTs.
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